Loading clinical trials...
Loading clinical trials...
INITIALL: Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma
Conditions
Interventions
Dexamethasone
Vincristine
+4 more
Locations
3
United States
Rady Children's Hospital
San Diego, California, United States
Saint Francis Children's Hospital
Tulsa, Oklahoma, United States
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Start Date
December 26, 2024
Primary Completion Date
May 1, 2034
Completion Date
May 1, 2039
Last Updated
March 3, 2026
NCT06735690
NCT06074666
NCT04972942
NCT07216443
NCT06395103
NCT07523555
Lead Sponsor
St. Jude Children's Research Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions